EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 323 filers reported holding EXELIXIS INC in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $579,000 | -16.7% | 32,720 | +0.5% | 0.02% | -17.4% |
| Q2 2019 | $695,000 | -2.9% | 32,544 | +8.2% | 0.02% | -8.0% |
| Q1 2019 | $716,000 | +36.6% | 30,064 | +12.9% | 0.02% | +19.0% |
| Q4 2018 | $524,000 | +19.1% | 26,624 | +7.1% | 0.02% | +40.0% |
| Q3 2018 | $440,000 | +85.7% | 24,848 | +154.2% | 0.02% | +66.7% |
| Q3 2017 | $237,000 | – | 9,776 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |